JNJvsMETA
Johnson & Johnson vs Meta Platforms Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.
Johnson & Johnson
$234.18
+16.15%
Meta Platforms Inc
$688.55
+3.81%
60-day price, rebased to 100
Round-by-round
Valuation upside
-49.50% vs -57.70% to DCF fair value
Balance-sheet strength
Altman Z 5.48 vs 25.49
Fundamental quality
Piotroski 4.00 vs 4.00 (of 9)
Growth + margins
Rule-of-40 -5.70 vs 56.60
60-day momentum
+7.18% vs -3.90% price return
Market-cap liquidity
$585.7B vs $1.26T
Verdict
Across 6 categories, META takes the edge with 3 wins to 2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.
Backtest a strategy on JNJ or META
Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.